{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:42:15Z","timestamp":1765806135931,"version":"3.41.2"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background and purpose<\/jats:title><jats:p>Aminosalicylates have been used for the prevention and treatment of radiation enteritis (RE) for more than 50\u00a0years. However, their effectiveness in acute radiation enteritis (ARE) has been controversial. We conducted a meta-analysis to clarify the clinical efficacy of aminosalicylates in controlling the symptoms of ARE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>We searched PubMed, Cochrane Library, Embase, and Web of Science for studies published before January 2020. Eligible randomized controlled trials (RCTs) comparing the incidence of diarrhea, abdominal pain, constipation, tenesmus, and hematochezia between the aminosalicylates and control groups were included. Subgroup analyses were conducted based on different drugs and doses. Publication bias was assessed using funnel plots.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Seven RCTs with 613 patients were included. Aminosalicylates reduced the incidence of mild to moderate diarrhea (P &amp;lt; 0.05), while total diarrhea, severe diarrhea, abdominal pain, hematochezia, tenesmus, and constipation showed no significant differences from the control group. Subgroup analysis showed that sulfasalazine (SASP) reduced mild to moderate diarrhea (P &amp;lt; 0.05), whereas 5-aminosalicylic acid (5-ASA) increased total and severe diarrhea (P &amp;lt; 0.05). Additionally, when aminosalicylate doses exceeded 2\u00a0g\/d, diarrhea incidence increased (P &amp;lt; 0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>SASP is a safe and effective treatment for mild to moderate diarrhea, while 5-ASA may increase diarrhea incidence in ARE patients. Aminosalicylates at \u22642\u00a0g\/d are safe for ARE, but higher doses may worsen diarrhea.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1544981","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T05:25:18Z","timestamp":1745299518000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The efficacy of aminosalicylates in acute radiation enteritis: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhendong","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuyan","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongsheng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wa","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.clon.2007.08.011","article-title":"Gastrointestinal problems after pelvic radiotherapy: the past, the present and the future","volume":"19","author":"Andreyev","year":"2007","journal-title":"Clin. Oncol. R. Coll. Radiologists (Great Britain)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1136\/bmj.2.5807.188","article-title":"Oral prostaglandins in the induction of labour","volume":"2","author":"Barr","year":"1972","journal-title":"Br. Med. J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/s0936-6555(05)80689-2","article-title":"A randomized trial to assess the efficacy of 5-aminosalicylic acid for the prevention of radiation enteritis","volume":"5","author":"Baughan","year":"1993","journal-title":"Clin. Oncol. R. Coll. Radiologists (Great Britain)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"765474","DOI":"10.3389\/fmed.2021.765474","article-title":"Treatment of inflammatory bowel disease: a comprehensive review","volume":"8","author":"Cai","year":"2021","journal-title":"Front. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.bioorg.2006.07.001","article-title":"Structure-activity relationship of for-L-Met L-Leu-L-Phe-OMe analogues in human neutrophils","volume":"34","author":"Cavicchioni","year":"2006","journal-title":"Bioorg. Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/gut.10.7.565","article-title":"Faecal flora of patients with ulcerative colitis during treatment with salicylazosulphapyridine","volume":"10","author":"Cooke","year":"1969","journal-title":"Gut"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/BF01314051","article-title":"Modulation of human colonic arachidonic acid metabolism by sulfasalazine","volume":"30","author":"Hawkey","year":"1985","journal-title":"Dig. Dis. Sci."},{"volume-title":"Chapter 8: assessing risk of bias in including studiesCochrane handbook for systematic reviews of interventions version 5.1. 0 (updated March 2011)","year":"2011","author":"Higgins","key":"B8"},{"key":"B9","doi-asserted-by":"publisher","first-page":"49e","DOI":"10.1097\/01.prs.0000440818.23647.0b","article-title":"Mechanisms of injury to normal tissue after radiotherapy: a review","volume":"133","author":"Hubenak","year":"2014","journal-title":"Plastic Reconstr. Surg."},{"key":"B10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/s0167-8140(00)00254-1","article-title":"Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of sulphasalazine in preventing acute gastrointestinal complications due to radiotherapy","volume":"57","author":"Kili\u00e7","year":"2000","journal-title":"Radiotherapy Oncol. J. Eur. Soc. Ther. Radiology Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1046\/j.1365-2036.1998.00360.x","article-title":"Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitis","volume":"12","author":"Kruis","year":"1998","journal-title":"Alimentary Pharmacol. and Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jviscsurg.2020.08.012","article-title":"Radiation enteritis: diagnostic and therapeutic issues","volume":"157","author":"Loge","year":"2020","journal-title":"J. Visc. Surg."},{"key":"B13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0360-3016(96)00016-8","article-title":"Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trial","volume":"35","author":"Martenson","year":"1996","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B14","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/s0140-6736(75)90358-x","article-title":"Treatment of radiation-induced gastrointestinal distress with acetylsalicylate","volume":"2","author":"Mennie","year":"1975","journal-title":"Lancet London, Engl."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.ijrobp.2016.01.063","article-title":"N08C9 (alliance): a phase 3 randomized study of sulfasalazine versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy","volume":"95","author":"Miller","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/09553002.2018.1440092","article-title":"Mechanisms of inflammatory responses to radiation and normal tissues toxicity: clinical implications","volume":"94","author":"Najafi","year":"2018","journal-title":"Int. J. Radiat. Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3109\/00365528809093864","article-title":"Sulfasalazine and 5-aminosalicylic acid inhibit contractile leukotriene formation","volume":"23","author":"Nielsen","year":"1988","journal-title":"Scand. J. Gastroenterol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ijrobp.2023.09.021","article-title":"Racecadotril versus loperamide in acute radiation enteritis: a randomized, double-masked, phase 3, noninferiority trial","volume":"118","author":"P","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4103\/2278-0513.113633","article-title":"A prospective randomized controlled trial to study the role of sulfasalazine in prevention of acute gastrointestinal toxicity associated with concurrent chemoradiation in carcinoma cervix","volume":"2","author":"Pal","year":"2013","journal-title":"Clin. Cancer Investig. J."},{"key":"B20","first-page":"660","article-title":"Therapy of radiogenic colitis with salicylazosulfapyridine (azulfidine)","volume":"143","author":"Rauch","year":"1972","journal-title":"Strahlentherapie"},{"key":"B21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/s0167-8140(97)00064-9","article-title":"A randomized double blind placebo controlled multicenter study of mesalazine for the prevention of acute radiation enteritis","volume":"44","author":"Resbeut","year":"1997","journal-title":"Radiotherapy Oncol. J. Eur. Soc. Ther. Radiology Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s00066-003-1082-4","article-title":"Sucralfate versus mesalazine versus hydrocortisone in the prevention of acute radiation proctitis during conformal radiotherapy for prostate carcinoma. A randomized study","volume":"179","author":"Sanguineti","year":"2003","journal-title":"Strahlenther. Onkol. Organ Dtsch. Rontgengesellschaft al"},{"key":"B23","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.lfs.2013.01.028","article-title":"Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice","volume":"92","author":"Sann","year":"2013","journal-title":"Life Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/intimm\/dxz044","article-title":"The leukotriene receptors as therapeutic targets of inflammatory diseases","volume":"31","author":"Sasaki","year":"2019","journal-title":"Int. Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/BF00184728","article-title":"Effect of olsalazine and mesalazine on human ileal and colonic (Na+ + K+)-ATPase","volume":"71","author":"Scheurlen","year":"1993","journal-title":"A possible diarrhogenic factor? Clin. investigator"},{"key":"B26","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1159\/000312669","article-title":"Cysteinyl leukotrienes and their receptors: molecular and functional characteristics","volume":"85","author":"Singh","year":"2010","journal-title":"Pharmacology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0006-2952(84)90233-8","article-title":"Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (FMLP) to its receptor on human neutrophils","volume":"33","author":"Stenson","year":"1984","journal-title":"Biochem. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA a cancer J. Clin."},{"key":"B29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0016-5085(90)90814-h","article-title":"Participation of thromboxane and other eicosanoid synthesis in the course of experimental inflammatory colitis","volume":"98","author":"Vilaseca","year":"1990","journal-title":"Gastroenterology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1055\/s-2008-1027150","article-title":"Medical prevention and treatment of acute and chronic radiation induced enteritis--is there any proven therapy? a short review","volume":"46","author":"Zimmerer","year":"2008","journal-title":"Z. fur Gastroenterol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1544981\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T05:25:19Z","timestamp":1745299519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1544981\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":30,"alternative-id":["10.3389\/fphar.2025.1544981"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1544981","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"article-number":"1544981"}}